Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer-Verlag
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428523/ |